Dow Down 0.62% Nasdaq Up 0.35%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqCM
0.14 Up 0.00(0.07%) Feb 10, 4:00PM EST
Prev Close:0.14
Open:0.14
Bid:0.13 x 100
Ask:0.40 x 400
1y Target Est:2.42
Beta:3.48407
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:0.14 - 0.15
52wk Range:0.13 - 1.47
Volume:1,142,853
Avg Vol (3m):1,755,050
Market Cap:27.30M
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTX

Comparison

Symbol% ChgMkt Cap
CYTXUp 0.07%27.30M
BAXUp 1.99%20.19B
OSIRUp 2.19%225.32M
ASTM 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.19
Quarterly EPS Est (Dec-15) :-0.04
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback